Al-Samkari H, Soff GA (2021) Clinical challenges and promising therapies for chemotherapy-induced thrombocytopenia. Expert Rev Hematol 14:437–448

Article  CAS  PubMed  Google Scholar 

Weycker D, Hatfield M, Grossman A, Hanau A, Lonshteyn A, Sharma A, Chandler D (2019) Risk and consequences of chemotherapy-induced thrombocytopenia in US clinical practice. BMC Cancer 19:151

Article  PubMed  PubMed Central  Google Scholar 

Shaw JL, Nielson CM, Park JK, Marongiu A, Soff GA (2021) The incidence of thrombocytopenia in adult patients receiving chemotherapy for solid tumors or hematologic malignancies. Eur J Haematol 106:662–672

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vinholt PJ (2019) The role of platelets in bleeding in patients with thrombocytopenia and haematological disease. Clin Chem Lab Med 57:1808–1817

Article  CAS  PubMed  Google Scholar 

Moik F, Makatsariya A, Ay C (2021) Challenging anticoagulation cases: Cancer-associated venous thromboembolism and chemotherapy-induced thrombocytopenia—a case-based review of clinical management. Thromb Res 199:38–42

Article  CAS  PubMed  Google Scholar 

Napolitano M, Saccullo G, Marietta M, Carpenedo M, Castaman G, Cerchiara E, Chistolini A, Contino L, De Stefano V, Falanga A, Federici AB, Rossi E, Santoro R, Siragusa S, Gruppo Italiano Malattie EMatologiche dell’Adulto (GIMEMA) (2019) Platelet cut-off for anticoagulant therapy in thrombocytopenic patients with blood cancer and venous thromboembolism: an expert consensus. Blood Transfus 17:171–180

PubMed  PubMed Central  Google Scholar 

Houghton DE, Key NS, Zakai NA, Laux JP, Shea TC, Moll S (2017) Analysis of anticoagulation strategies for venous thromboembolism during severe thrombocytopenia in patients with hematologic malignancies: a retrospective cohort. Leuk Lymphoma 58:2573–2581

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carney BJ, Wang TF, Ren S, George G, Al Homssi A, Gaddh M, Connolly GC, Shah VI, Bogue T, Bartosic A, Neuberg D, Baumann Kreuziger L, Zwicker JI, VENUS Network Investigators (2021) Anticoagulation in cancer-associated thromboembolism with thrombocytopenia: a prospective, multicenter cohort study. Blood Adv 5:5546–5553

Article  CAS  PubMed  PubMed Central  Google Scholar 

Samuelson Bannow BT, Lee A, Khorana AA, Zwicker JI, Noble S, Ay C, Carrier M (2018) Management of cancer-associated thrombosis in patients with thrombocytopenia: guidance from the SSC of the ISTH. J Thromb Haemost 16:1246–1249

Article  CAS  PubMed  Google Scholar 

Leader A, Ten Cate V, Ten Cate-Hoek AJ, Beckers EAM, Spectre G, Giaccherini C, Gurevich-Shapiro A, Krashin E, Raanani P, Schouten HC, Falanga A, Hugo Ten Cate H (2020) Anticoagulation in thrombocytopenic patients with hematological malignancy: a multinational clinical vignette-based experiment. Eur J Intern Med 77:86–96

Article  PubMed  Google Scholar 

Kekre N, Connors JM (2019) Venous thromboembolism incidence in hematologic malignancies. Blood Rev 33:24–32

Article  PubMed  Google Scholar 

De Stefano V, Sora F, Rossi E, Chiusolo P, Laurenti L, Fianchi L, Zini G, Pagano L, Sica S, Leone G (2005) The risk of thrombosis in patients with acute leukemia: occurrence of thrombosis at diagnosis and during treatment. J Thromb Haemost 3:1985–1992

Article  PubMed  Google Scholar 

Angelini DE, Radivoyevitch T, McCrae KR, Khorana AA (2019) Bleeding incidence and risk factors among cancer patients treated with anticoagulation. Am J Hematol 94:780–785

Article  CAS  PubMed  Google Scholar 

Khanal N, Bociek RG, Chen B, Vose JM, James O Armitage JO, Bierman PJ, Maness LJ, Lunning MA, Gundabolu K, Bhatt VR (2016) Venous thromboembolism in patients with hematologic malignancy and thrombocytopenia. Am J Hematol 91:E468–E472

Article  CAS  PubMed  Google Scholar 

Joks M, Czyż A, Popławski D, Komarnicki M (2014) Incidence and risk factors for central venous catheter-related thrombosis in hematological patients. Med Oncol 31:772

Article  PubMed  Google Scholar